SAB Biotherapeutics (SABS) Shares Issued (2020 - 2026)

SAB Biotherapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Shares Issued rose 75.11% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 75.11% YoY) and the FY2025 annual result came in at $20.9 million, up 603.78% from the prior year.
• Shares Issued was $1.6 million for Q1 2026 at SAB Biotherapeutics, down from $20.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $20.9 million in Q4 2025 and bottomed at $709470.0 in Q4 2022.
• A 5-year average of $5.1 million and a median of $3.1 million in 2024 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2024 — Shares Issued sank 81.02% — and 2025, when it jumped 603.78%.
• SAB Biotherapeutics' Shares Issued stood at $709470.0 in 2022, then surged by 42.29% to $1.0 million in 2023, then jumped by 194.0% to $3.0 million in 2024, then soared by 603.78% to $20.9 million in 2025, then tumbled by 92.55% to $1.6 million in 2026.
• Business Quant data shows SABS's Shares Issued at $1.6 million in Q1 2026, $20.9 million in Q4 2025, and $6.7 million in Q3 2025.